M Blank Selected Research

Fetal Resorption

1/2003	Anti-prothrombin antibodies cause thrombosis in a novel qualitative ex-vivo animal model.
11/2002	The effects of IgG purified from women with SLE and associated pregnancy loss on rat embryos in culture.
7/2000	Anti-cardiolipin antibody from a patient with antiphospholipid syndrome (APS) recognizes only an epitope expressed by cardiolipin/beta 2-glycoprotein-I (beta 2GPI) complex and induces APS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Blank Research Topics

Disease

25	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2017 - 03/2000
12	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2000
11	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2015 - 03/2000
7	Thrombosis (Thrombus) 02/2015 - 07/2000
6	Rheumatoid Arthritis 01/2021 - 01/2003
5	Neoplasms (Cancer) 09/2015 - 01/2000
5	Thrombocytopenia (Thrombopenia) 01/2003 - 07/2000
4	Inflammation (Inflammations) 01/2021 - 01/2000
4	Proteinuria 01/2018 - 10/2000
3	Experimental Arthritis 01/2021 - 12/2015
3	Rheumatic Diseases (Rheumatism) 01/2018 - 09/2010
3	Rubella (German Measles) 11/2013 - 11/2009
3	Pemphigus (Pemphigus Vulgaris) 12/2010 - 12/2005
3	Infections 09/2009 - 07/2000
3	Epilepsy (Aura) 01/2007 - 09/2005
3	Fetal Resorption 01/2003 - 07/2000
3	Atherosclerosis 08/2001 - 12/2000
2	Arthritis (Polyarthritis) 01/2021 - 01/2021
2	Sepsis (Septicemia) 01/2021 - 12/2014
2	Body Weight (Weight, Body) 01/2018 - 07/2007
2	Glomerulonephritis 01/2018 - 09/2010
2	Necrosis 04/2016 - 01/2000
2	Hyperferritinemia 12/2014 - 11/2013
2	Acantholysis 12/2010 - 01/2006
2	Spontaneous Abortion (Miscarriage) 01/2003 - 01/2001
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 11/2002 - 08/2000
2	Muscular Dystrophies (Muscular Dystrophy) 01/2002 - 09/2000
2	Coronary Artery Disease (Coronary Atherosclerosis) 02/2001 - 01/2001
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2000 - 03/2000
2	Vascular Diseases (Vascular Disease) 08/2000 - 03/2000
2	Takayasu Arteritis (Arteritis, Takayasu's) 08/2000 - 07/2000
1	Lupus Nephritis 01/2018
1	Muscular Diseases (Myopathy) 01/2017
1	Esophageal Motility Disorders (Nutcracker Esophagus) 09/2016
1	Oncogene Addiction 09/2015
1	Hepatocellular Carcinoma (Hepatoma) 09/2015
1	Adult-Onset Still's Disease 12/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 11/2013
1	Intellectual Disability (Idiocy) 07/2013
1	Down Syndrome (Down's Syndrome) 07/2013

Drug/Important Bio-Agent (IBA)

37	AntibodiesIBA 01/2021 - 03/2000
16	AutoantibodiesIBA 01/2017 - 03/2000
9	Immunoglobulin G (IgG)IBA 02/2015 - 11/2002
8	Peptides (Polypeptides)IBA 02/2015 - 03/2000
8	Antiphospholipid AntibodiesIBA 06/2012 - 07/2000
6	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 12/2005
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2001
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2009
5	AntigensIBA 11/2009 - 12/2005
5	beta 2-Glycoprotein I (Apolipoprotein H)IBA 01/2005 - 01/2001
4	CytokinesIBA 01/2021 - 01/2000
4	Immunoglobulin M (IgM)IBA 11/2013 - 01/2003
4	Phospholipids (Phosphatides)FDA LinkGeneric 01/2011 - 07/2000
4	Cardiolipins (Cardiolipin)IBA 01/2003 - 07/2000
3	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 11/2002
3	Amino Acids FDA Link 02/2015 - 03/2000
3	anti-endothelial cell antibodyIBA 11/2002 - 08/2000
3	oxidized low density lipoproteinIBA 02/2001 - 12/2000
2	InterleukinsIBA 01/2021 - 04/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2003
2	CollagenIBA 01/2021 - 04/2016
2	tuftsin-phosphorylcholineIBA 01/2018 - 04/2016
2	Anti-Idiotypic AntibodiesIBA 12/2015 - 12/2010
2	Ferritins (Ferritin)IBA 12/2014 - 11/2013
2	VaccinesIBA 06/2012 - 11/2009
2	Thromboplastin (Tissue Factor)IBA 01/2011 - 07/2000
2	DesmogleinsIBA 12/2010 - 01/2006
2	DNA (Deoxyribonucleic Acid)IBA 09/2010 - 01/2003
2	EpitopesIBA 06/2007 - 07/2000
2	Immunoglobulin A (IgA)IBA 01/2006 - 01/2003
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 12/2005 - 03/2000
2	Glycoproteins (Glycoprotein)IBA 01/2003 - 09/2000
2	DystrophinIBA 01/2002 - 09/2000
2	hypericinIBA 08/2001 - 01/2000
1	ammonium trichloro(dioxoethylene-O,O'-)tellurate (AS 101)IBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	InterferonsIBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	TelluriumIBA 01/2021
1	tofacitinibIBA 01/2019
1	Methylprednisolone FDA LinkGeneric 01/2018
1	anti-dsDNA autoantibodyIBA 01/2018
1	Phosphates (Orthophosphate)IBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	Annexin A2 (Annexin II)IBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	AcidsIBA 09/2016
1	Interleukin-10 (Interleukin 10)IBA 04/2016
1	TuftsinIBA 04/2016
1	Anti-Citrullinated Protein AntibodiesIBA 12/2015
1	ChromatinIBA 09/2015
1	Epithelial Cell Adhesion MoleculeIBA 09/2015
1	Pentylenetetrazole (Metrazol)IBA 07/2013
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 06/2012

Therapy/Procedure

9	Therapeutics 01/2021 - 03/2000
2	Immunomodulation 12/2015 - 01/2000
1	Liver Transplantation 09/2015
1	Drug Therapy (Chemotherapy) 07/2013